Liping Liu, HighTide Therapeutics founder and CEO
December 14, 2023 07:29 AM ESTUpdated 07:53 AM
Financing

Up­dat­ed: Meta­bol­ic drug de­vel­op­er High­T­ide Ther­a­peu­tics eyes $36M raise with HK IPO

Amber Tong

High­T­ide Ther­a­peu­tics, a biotech de­vel­op­ing drugs for meta­bol­ic and di­ges­tive dis­eases in both the US and Chi­na, is seek­ing to raise around $36 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Evotec gains on Halozyme's takeover pro­pos­al

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Adap­ti­m­mune to 're­de­fine' it­self as a sar­co­ma biotech, cuts a third of staffers

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

Eli Lil­ly sues the US gov­ern­ment over its pro­posed 340B re­bate mod­el

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times